Kazuhiko Ohnuma

Kazuhiko Ohnuma

Auto-generated profile, based on publicly available information

Kazuhiko Ohnuma

Laboratorio de Lente Verde, 98-1 Nozomino, Sodegaura, Chiba, 299-0251, Japan

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 June 2013 in Graefe's Archive for Clinical and Experimental Ophthalmology
Verified
Journal Article
Closed access
PDF file
Takefumi YamaguchiTakefumi Yamaguchi
Takefumi Yamaguchi
KOKazuhiko Ohnuma
Kazuhiko Ohnuma
KKKenji Konomi
Kenji Konomi
YSYoshiyuki Satake
Yoshiyuki Satake
Jun ShimazakiJun Shimazaki
Jun Shimazaki
KNKazuno Negishi
Kazuno Negishi

1 June 2022 in Journal of Cataract & Refractive Surgery
Verified
Journal Article
Open access
SGSo Goto
So Goto
NMNaoyuki Maeda
Naoyuki Maeda
KOKazuhiko Ohnuma
Kazuhiko Ohnuma
TLTjundewo Lawu
Tjundewo Lawu
RKRyo Kawasaki
Ryo Kawasaki
TNToru Noda
Toru Noda
Purpose: To evaluate the performance of a new formula of intraocular lens (IOL) power calculation (the O formula) based on ray tracing without commonly used parameters, including ultrasound-compatible axial length, keratometry readings, and A-constant. Setting: Tokyo Medical Center, Tokyo, Japan. Design: Retrospective consecutive case series. Methods: 423 eyes (423 patients) implanted with a single-piece, L-loop, acrylic IOL were enrolled. All biometric data for the O formula were obtained by anterior segment swept-source optical coherence tomography (SS-OCT) and SS-OCT–based biometer. The performance of the O formula was compared with those of the Barrett Universal II (BUII) and Kane formulas at 1 month postoperatively. Statistical analysis was applied according to a heteroscedastic test with SD of prediction errors as the main parameter for formula performance. Results: The SD of the O formula (0.426) was statistically significantly lower than that of the BUII formula (0.464, P = .034) but not statistically significantly different from that of the Kane formula (0.433, P = .601). The percentages of patients with refractive prediction errors within ±0.50 diopter (D) and ±1.00 D of the O, BUII, and Kane formulas were 75.4% and 98.6%, 77.1% and 97.9%, and 76.6% and 98.1%, respectively. Conclusions: The O formula, based on ray tracing using SS-OCT–based devices, is one of the promising approaches for IOL power calculation, although additional larger scale studies are needed. It may be used as an alternative in IOL power calculation because of its independence from commonly used parameters.